CStone Pharmaceuticals
HKEX:2616
CStone Pharmaceuticals
Research & Development
CStone Pharmaceuticals
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
CStone Pharmaceuticals
HKEX:2616
|
Research & Development
-¥501.4m
|
CAGR 3-Years
29%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Research & Development
-¥12.5B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Research & Development
-¥2.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Research & Development
-¥1.1B
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Research & Development
-¥988.6m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
N/A
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Research & Development
-¥168.2m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
N/A
|
See Also
What is CStone Pharmaceuticals's Research & Development?
Research & Development
-501.4m
CNY
Based on the financial report for Dec 31, 2023, CStone Pharmaceuticals's Research & Development amounts to -501.4m CNY.
What is CStone Pharmaceuticals's Research & Development growth rate?
Research & Development CAGR 5Y
10%
Over the last year, the Research & Development growth was 15%. The average annual Research & Development growth rates for CStone Pharmaceuticals have been 29% over the past three years , 10% over the past five years .